PORD
MCID: CYT014
MIFTS: 33

Cytochrome P450 Oxidoreductase Deficiency (PORD)

Categories: Bone diseases, Endocrine diseases, Reproductive diseases

Aliases & Classifications for Cytochrome P450 Oxidoreductase Deficiency

MalaCards integrated aliases for Cytochrome P450 Oxidoreductase Deficiency:

Name: Cytochrome P450 Oxidoreductase Deficiency 24 25
Antley-Bixler Syndrome with Disordered Steroidogenesis 25 71
Por Deficiency 24 25
Pord 24 25
Congenital Adrenal Hyperplasia Due to Apparent Combined P450c17 and P450c21 Deficiency 25
Antley-Bixler Syndrome-Like Phenotype with Disordered Steroidogenesis 25
Combined Partial Deficiency of 17-Hydroxylase and 21-Hydroxylase 25
Antley-Bixler Syndrome, Autosomal Dominant 71
Antley-Bixler Syndrome 25

Classifications:



External Ids:

UMLS 71 C1860042 C2936791

Summaries for Cytochrome P450 Oxidoreductase Deficiency

Genetics Home Reference : 25 Cytochrome P450 oxidoreductase deficiency is a disorder of hormone production. This condition specifically affects steroid hormones, which are needed for normal development and reproduction. The hormonal changes associated with cytochrome P450 oxidoreductase deficiency can affect the development of the reproductive system, skeleton, and other parts of the body. These signs and symptoms are usually present at birth or become apparent in early childhood. The signs and symptoms of cytochrome P450 oxidoreductase deficiency vary from mild to severe. Signs and symptoms of mild cases can include a failure to begin menstruation by age 16 (primary amenorrhea), an inability to have biological children (infertility) in both men and women, and a condition called polycystic ovarian syndrome (PCOS). PCOS is characterized by a hormonal imbalance in women that can lead to irregular menstruation, acne, excess body hair (hirsutism), and weight gain. People with moderate cases of cytochrome P450 oxidoreductase deficiency may have external genitalia that do not look clearly male or female (ambiguous genitalia), and they may have infertility. People with moderate cytochrome P450 oxidoreductase deficiency usually do not have skeletal abnormalities. The severe form of cytochrome P450 oxidoreductase deficiency is sometimes called Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis. Hormonal changes in affected males and females lead to the development of ambiguous genitalia or other genital abnormalities, as well as infertility. Severe cases are also characterized by skeletal abnormalities, particularly involving bones of the head and face. These include premature fusion of the skull bones (craniosynostosis), a flattened mid-face, a prominent forehead, and low-set ears. Other skeletal abnormalities can include joint deformities (contractures) that limit movement; unusually long, slender fingers (arachnodactyly); bowing of the thigh bones; and radiohumeral synostosis, which is a bone abnormality that locks the elbows in a bent position. A blockage of the nasal passages (choanal atresia), intellectual disability, and delayed development are also associated with the severe form of the disorder. Some women who are pregnant with fetuses affected by cytochrome P450 oxidoreductase deficiency experience mild symptoms of the disorder even though they themselves do not have the disorder. They may develop excessive body hair growth (hirsutism), acne, and a deep voice. These changes go away soon after delivery.

MalaCards based summary : Cytochrome P450 Oxidoreductase Deficiency, also known as antley-bixler syndrome with disordered steroidogenesis, is related to humeroradial synostosis and radioulnar synostosis. An important gene associated with Cytochrome P450 Oxidoreductase Deficiency is POR (Cytochrome P450 Oxidoreductase), and among its related pathways/superpathways are Aldosterone synthesis and secretion and Cytochrome P450 - arranged by substrate type. Affiliated tissues include bone, lung and testes, and related phenotypes are behavior/neurological and cardiovascular system

GeneReviews: NBK1419

Related Diseases for Cytochrome P450 Oxidoreductase Deficiency

Diseases related to Cytochrome P450 Oxidoreductase Deficiency via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 97, show less)
# Related Disease Score Top Affiliating Genes
1 humeroradial synostosis 30.6 POR FGFR2
2 radioulnar synostosis 30.4 POR FGFR2
3 luteoma 30.3 FGFR2 CYP21A2
4 amenorrhea 30.0 POR POMC CYP17A1
5 hyperandrogenism 30.0 POMC CYP21A2 CYP17A1
6 antley-bixler syndrome without genital anomalies or disordered steroidogenesis 29.9 POR FGFR2
7 synostosis 29.9 POR FGFR2
8 sex development disorder 29.7 POMC CYP21A2 CYP17A1
9 lipoid congenital adrenal hyperplasia 29.7 POR POMC CYP21A2 CYP17A1
10 polycystic ovary syndrome 29.6 POMC CYP21A2 CYP17A1
11 hypospadias 29.4 FGFR2 CYP17A1
12 antley-bixler syndrome 28.1 POR POMC FGFR2 CYP21A2 CYP1A2 CYP17A1
13 disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency 13.2
14 aromatase deficiency 12.0
15 antley-bixler syndrome with genital anomalies and disordered steroidogenesis 12.0
16 bartter syndrome, type 2, antenatal 11.6
17 bartter syndrome, type 1, antenatal 11.6
18 choanal atresia, posterior 10.8
19 pfeiffer syndrome 10.6
20 fgfr-related craniosynostosis syndromes 10.6
21 familial glucocorticoid deficiency 10.6
22 clubfoot 10.6
23 trigonocephaly 1 10.5
24 chiari malformation type ii 10.5
25 respiratory failure 10.5
26 ankylosis 10.5
27 chiari malformation 10.5
28 isolated trigonocephaly 10.5
29 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 10.4
30 cleft palate, isolated 10.3
31 clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly 10.3
32 jackson-weiss syndrome 10.3
33 crouzon syndrome 10.3
34 down syndrome 10.3
35 renal hypodysplasia/aplasia 1 10.3
36 alacrima, achalasia, and mental retardation syndrome 10.3
37 bone disease 10.3
38 esophageal atresia 10.3
39 hydronephrosis 10.3
40 obstructive hydrocephalus 10.3
41 hypogonadism 10.3
42 dysostosis 10.3
43 hemangioma 10.3
44 hypogonadotropism 10.3
45 chromosomal triplication 10.3
46 congenital femoral deficiency 10.3
47 congenital hydrocephalus 10.3
48 fetal aminopterin syndrome 10.3
49 lambdoid synostosis 10.3
50 vaginal atresia 10.3
51 overgrowth syndrome 10.3
52 vesicoureteral reflux 1 10.3
53 autosomal recessive disease 10.3
54 ovarian cyst 10.3
55 earlobe crease 10.1
56 anus, imperforate 10.1
57 cryptorchidism, unilateral or bilateral 10.1
58 sexual disorder 10.1
59 hydrocephalus 10.1
60 gastroenteritis 10.1
61 craniosynostosis 10.1
62 exophthalmos 10.1
63 penile agenesis 10.1
64 syndrome with 46,xy disorder of sex development 10.1
65 autoimmune hepatitis type 2 10.0 CYP21A2 CYP17A1
66 inherited metabolic disorder 10.0 POMC CYP21A2
67 azoospermia 10.0
68 transsexualism 10.0 CYP21A2 CYP17A1
69 acute adrenal insufficiency 10.0 POMC CYP21A2
70 classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency 10.0 POMC CYP21A2
71 adrenal rest tumor 9.9 POMC CYP21A2
72 leydig cell tumor 9.9 CYP21A2 CYP17A1
73 laryngeal tuberculosis 9.9 POMC CYP21A2
74 mineral metabolism disease 9.9 POMC CYP17A1
75 achalasia-addisonianism-alacrima syndrome 9.9 POMC CYP21A2
76 hypoadrenalism 9.9 POMC CYP1A2
77 gynecomastia 9.8 POMC CYP21A2
78 pseudohermaphroditism 9.8 POMC CYP17A1
79 neurofibromatosis, type ii 9.8 POMC CYP21A2
80 hypokalemia 9.7 POMC CYP17A1
81 46 xy gonadal dysgenesis 9.7 POR CYP21A2 CYP17A1
82 cortisone reductase deficiency 9.7 POR POMC CYP21A2
83 adrenal cortical hypofunction 9.7 POMC CYP21A2 CYP17A1
84 sebaceous gland disease 9.7 POMC CYP21A2 CYP17A1
85 adrenal cortical carcinoma 9.7 POMC CYP21A2 CYP17A1
86 adrenal cortex disease 9.7 POMC CYP21A2 CYP17A1
87 adrenal cortical adenoma 9.7 POMC CYP21A2 CYP17A1
88 hypoadrenocorticism, familial 9.7 POMC CYP21A2 CYP17A1
89 adrenal gland disease 9.7 POMC CYP21A2 CYP17A1
90 adrenal adenoma 9.6 POMC CYP21A2 CYP17A1
91 adrenal carcinoma 9.6 POMC CYP21A2 CYP17A1
92 autoimmune polyendocrine syndrome, type i, with or without reversible metaphyseal dysplasia 9.6 CYP21A2 CYP1A2 CYP17A1
93 conn's syndrome 9.6 POMC CYP21A2 CYP17A1
94 asperger syndrome 9.5 CYP21A2 CYP17A1
95 adrenal insufficiency, congenital, with 46,xy sex reversal, partial or complete 9.4 POR POMC CYP21A2 CYP17A1
96 steroid inherited metabolic disorder 9.4 POR POMC CYP21A2 CYP17A1
97 diabetes mellitus, noninsulin-dependent 9.0 POMC CYP21A2 CYP1A2 CYP17A1

Graphical network of the top 20 diseases related to Cytochrome P450 Oxidoreductase Deficiency:



Diseases related to Cytochrome P450 Oxidoreductase Deficiency

Symptoms & Phenotypes for Cytochrome P450 Oxidoreductase Deficiency

MGI Mouse Phenotypes related to Cytochrome P450 Oxidoreductase Deficiency:

45 (showing 4, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.73 CYP17A1 CYP1A2 CYP21A2 FGFR2 POMC POR
2 cardiovascular system MP:0005385 9.55 CYP17A1 CYP1A2 FGFR2 POMC POR
3 liver/biliary system MP:0005370 9.26 CYP1A2 FGFR2 POMC POR
4 mortality/aging MP:0010768 9.1 CYP17A1 CYP1A2 CYP21A2 FGFR2 POMC POR

Drugs & Therapeutics for Cytochrome P450 Oxidoreductase Deficiency

Interventional clinical trials:

(showing 1, show less)
# Name Status NCT ID Phase Drugs
1 Investigations Into Inborn Errors of Cholesterol Synthesis and Related Disorders Recruiting NCT00046202

Search NIH Clinical Center for Cytochrome P450 Oxidoreductase Deficiency

Genetic Tests for Cytochrome P450 Oxidoreductase Deficiency

Anatomical Context for Cytochrome P450 Oxidoreductase Deficiency

MalaCards organs/tissues related to Cytochrome P450 Oxidoreductase Deficiency:

40
Bone, Lung, Testes, Liver, Temporal Lobe, Fetal Lung, Cortex

Publications for Cytochrome P450 Oxidoreductase Deficiency

Articles related to Cytochrome P450 Oxidoreductase Deficiency:

(showing 94, show less)
# Title Authors PMID Year
1
P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms. 61 24
27068427 2017
2
Long-term follow-up of a female with congenital adrenal hyperplasia due to P450-oxidoreductase deficiency. 61 24
27737328 2016
3
Pharmacogenomics of human P450 oxidoreductase. 61 24
24847272 2014
4
Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency. 61 24
23365120 2013
5
Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. 61 24
22162478 2012
6
Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients. 61 24
19258400 2009
7
Predictive value of fetal lung volume in prenatally diagnosed skeletal dysplasia. 24
25102973 2014
8
Temporal lobe dysplasia: a characteristic sonographic finding in thanatophoric dysplasia. 24
24585534 2014
9
Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid. 24
22019272 2011
10
Proximal promoter of the cytochrome P450 oxidoreductase gene: identification of microdeletions involving the untranslated exon 1 and critical function of the SP1 binding sites. 24
21900384 2011
11
Pubertal presentation in seven patients with congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. 24
21190981 2011
12
Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. 24
20844025 2010
13
Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase. 24
20697309 2010
14
Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism. 24
20849814 2010
15
Restoration of mutant cytochrome P450 reductase activity by external flavin. 24
20188793 2010
16
Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients. 24
19837910 2009
17
The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test. 24
19801957 2009
18
Steroid 17alpha-hydroxylase deficiency: functional characterization of four mutations (A174E, V178D, R440C, L465P) in the CYP17A1 gene. 24
19454579 2009
19
Genetic variation in human P450 oxidoreductase. 24
18930113 2009
20
Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency. 24
18957504 2009
21
Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency. 24
18559916 2008
22
Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase. 24
18455494 2008
23
Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19. 24
18551037 2008
24
P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity. 24
18433346 2008
25
Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations. 24
18230729 2008
26
Genetic and clinical features of p450 oxidoreductase deficiency. 24
18259105 2008
27
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase. 24
17595315 2007
28
Differential inhibition of CYP17A1 and CYP21A2 activities by the P450 oxidoreductase mutant A287P. 24
17505056 2007
29
Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency. 24
17389698 2007
30
Benchmarking sets for molecular docking. 24
17154509 2006
31
Linking Antley-Bixler syndrome and congenital adrenal hyperplasia: a novel case of P450 oxidoreductase deficiency. 24
16906539 2006
32
Sterol profiling of amniotic fluid: a routine method for the detection of distal cholesterol synthesis deficit. 24
16231320 2005
33
Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype. 24
16265639 2005
34
Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. 24
15793702 2005
35
Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. 24
15483095 2005
36
Undetectable maternal serum uE3 and postnatal abnormal sterol and steroid metabolism in Antley-Bixler syndrome. 24
15266606 2004
37
Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome. 24
15264278 2004
38
Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): a disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype. 24
15316970 2004
39
Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. 24
15220035 2004
40
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. 24
14758361 2004
41
Apparent pregnene hydroxylation deficiency (APHD): seeking the parentage of an orphan metabolome. 24
14625002 2003
42
Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic Acid homeostasis. 24
12917333 2003
43
Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. 24
12697746 2003
44
Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia. 24
12116245 2002
45
Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. 24
11742006 2002
46
Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. 24
9332650 1997
47
Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. 24
2932643 1985
48
Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency: based on the first cohort of Chinese children. 61
31888681 2019
49
The mechanism of Psoralen and Isopsoralen hepatotoxicity as revealed by hepatic gene expression profiling in SD rats. 61
31271704 2019
50
P450 oxidoreductase deficiency: A systematic review and meta-analysis of genotypes, phenotypes and their relationships. 61
31825489 2019
51
Letter to the Editor: Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect (SMMR, Vol. 28, Issue 2, 2019). 61
29633629 2019
52
Authors' reply: Letter to the Editor: Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect (SMMR, Vol. 28, Issue 2, 2019). 61
29633630 2019
53
Comment to the reply letter: Letter to the Editor: Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect (SMMR, Vol. 28, Issue 2, 2019). 61
29633654 2019
54
Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect. 61
29121828 2019
55
The pharmacological interactions between direct-acting antivirals for the treatment of chronic hepatitis c and psychotropic drugs. 61
30199279 2018
56
SULFATION PATHWAYS: Alternate steroid sulfation pathways targeted by LC-MS/MS analysis of disulfates: application to prenatal diagnosis of steroid synthesis disorders. 61
29459491 2018
57
In vitro fertilization-frozen embryo transfer in a patient with cytochrome P450 oxidoreductase deficiency: a case report. 61
29069987 2018
58
Longitudinal serum and urine steroid metabolite profiling in a 46,XY infant with prenatally identified POR deficiency. 61
29289577 2018
59
Continuous Pulse Oximetry and Capnography Monitoring for Postoperative Respiratory Depression and Adverse Events: A Systematic Review and Meta-analysis. 61
29064874 2017
60
Resistance of Helicobacter pylori to furazolidone and levofloxacin: A viewpoint. 61
29085236 2017
61
Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review. 61
28288674 2017
62
Cytochrome P450 Oxidoreductase Deficiency: Novel Cause of Ambiguity with Primary Amenorrhea. 61
28459039 2017
63
P450 Oxidoreductase Deficiency: Loss of Activity Caused by Protein Instability From a Novel L374H Mutation. 61
27603900 2016
64
Respiratory volume monitoring in an obese surgical population and the prediction of postoperative respiratory depression by the STOP-bang OSA risk score. 61
27687395 2016
65
Classic and non-classic 21-hydroxylase deficiency can be discriminated from P450 oxidoreductase deficiency in Japanese infants by urinary steroid metabolites. 61
27212795 2016
66
A Local, Self-Organizing Reaction-Diffusion Model Can Explain Somite Patterning in Embryos. 61
27136055 2015
67
Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency. 61
25728647 2015
68
Cytochrome P450 oxidoreductase deficiency: rare congenital disorder leading to skeletal malformations and steroidogenic defects. 61
25294558 2014
69
Disorder of sex development as a diagnostic clue in the first Spanish known newborn with P450 oxidoreductase deficiency. 61
23878291 2013
70
[Acute renal failure after cardiac surgery: evaluation of the RIFLE criteria]. 61
22921449 2013
71
Backdoor pathway for dihydrotestosterone biosynthesis: implications for normal and abnormal human sex development. 61
23073980 2013
72
Borders and comparative cytoarchitecture of the perirhinal and postrhinal cortices in an F1 hybrid mouse. 61
22368084 2013
73
[Kinetics, diagnostic and prognostic value of procalcitonin after cardiac surgery]. 61
23047903 2012
74
Two-step biochemical differential diagnosis of classic 21-hydroxylase deficiency and cytochrome P450 oxidoreductase deficiency in Japanese infants by GC-MS measurement of urinary pregnanetriolone/ tetrahydroxycortisone ratio and 11β-hydroxyandrosterone. 61
22273564 2012
75
Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency. 61
21808038 2011
76
Anorectal and urinary anomalies and aberrant retinoic acid metabolism in cytochrome P450 oxidoreductase deficiency. 61
20409737 2010
77
Ambiguous genitalia, impaired steroidogenesis, and Antley-Bixler syndrome in a patient with P450 oxidoreductase deficiency. 61
20124576 2010
78
Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect. 61
19884324 2010
79
Copper and cadmium: responses in Pseudomonas putida KT2440. 61
19843215 2009
80
Cytochrome P450 oxidoreductase deficiency with Antley-Bixler syndrome: steroidogenic capacities. 61
19618668 2009
81
Novel non-HLA-susceptible regions determined by meta-analysis of four genomewide scans for ankylosing spondylitis. 61
18560177 2008
82
Basic concepts and recent developments in human steroid hormone biosynthesis. 61
17926129 2007
83
Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone. 61
16608896 2006
84
Mutations in Helicobacter pylori porD and oorD genes may contribute to furazolidone resistance. 61
16758519 2006
85
Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: diagnostic value of urine steroid hormone analysis. 61
16439592 2006
86
Anabolic five subunit-type pyruvate:ferredoxin oxidoreductase from Hydrogenobacter thermophilus TK-6. 61
16343420 2006
87
Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. 61
16208513 2005
88
Cytochrome P450 Oxidoreductase Deficiency 61
20301592 2005
89
Percutaneous compression plating for intertrochanteric fractures. Surgical technique, tips for surgery, and results. 61
16007384 2005
90
Ankylosing spondylitis susceptibility loci defined by genome-search meta-analysis. 61
16175319 2005
91
Borders and cytoarchitecture of the perirhinal and postrhinal cortices in the rat. 61
11477594 2001
92
Helicobacter pylori porCDAB and oorDABC genes encode distinct pyruvate:flavodoxin and 2-oxoglutarate:acceptor oxidoreductases which mediate electron transport to NADP. 61
9495749 1998
93
Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas. 61
8682589 1996
94
Transcriptional activation of cytochrome P450 2B1/2 genes in rat liver by diallyl sulfide, a compound derived from garlic. 61
8489239 1993

Variations for Cytochrome P450 Oxidoreductase Deficiency

Copy number variations for Cytochrome P450 Oxidoreductase Deficiency from CNVD:

7 (showing 1, show less)
# CNVD ID Chromosome Start End Type Gene Symbol CNVD Disease
1 180701 4 109188149 109309027 Microdeletion LEF1 Cytochrome P450 oxidoreductase deficiency

Expression for Cytochrome P450 Oxidoreductase Deficiency

Search GEO for disease gene expression data for Cytochrome P450 Oxidoreductase Deficiency.

Pathways for Cytochrome P450 Oxidoreductase Deficiency

Pathways related to Cytochrome P450 Oxidoreductase Deficiency according to GeneCards Suite gene sharing:

(showing 8, show less)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.38 POMC CYP21A2 CYP17A1
2
Show member pathways
12.35 POR POMC CYP21A2 CYP1A2 CYP17A1
3 11.37 POMC CYP21A2
4
Show member pathways
11.3 POR CYP1A2
5
Show member pathways
11.28 POMC CYP21A2 CYP17A1
6
Show member pathways
11.05 CYP1A2 CYP17A1
7
Show member pathways
10.62 CYP21A2 CYP1A2 CYP17A1
8
Show member pathways
10.6 CYP21A2 CYP17A1

GO Terms for Cytochrome P450 Oxidoreductase Deficiency

Cellular components related to Cytochrome P450 Oxidoreductase Deficiency according to GeneCards Suite gene sharing:

(showing 4, show less)
# Name GO ID Score Top Affiliating Genes
1 endoplasmic reticulum GO:0005783 9.56 POR CYP21A2 CYP1A2 CYP17A1
2 endoplasmic reticulum membrane GO:0005789 9.46 POR CYP21A2 CYP1A2 CYP17A1
3 organelle membrane GO:0031090 9.13 CYP21A2 CYP1A2 CYP17A1
4 intracellular membrane-bounded organelle GO:0043231 9.02 POR FGFR2 CYP21A2 CYP1A2 CYP17A1

Biological processes related to Cytochrome P450 Oxidoreductase Deficiency according to GeneCards Suite gene sharing:

(showing 8, show less)
# Name GO ID Score Top Affiliating Genes
1 oxidation-reduction process GO:0055114 9.46 POR CYP21A2 CYP1A2 CYP17A1
2 xenobiotic metabolic process GO:0006805 9.43 POR CYP1A2
3 lung development GO:0030324 9.4 FGFR2 CYP1A2
4 electron transport chain GO:0022900 9.37 POR CYP1A2
5 post-embryonic development GO:0009791 9.32 FGFR2 CYP1A2
6 steroid biosynthetic process GO:0006694 9.26 CYP21A2 CYP17A1
7 steroid metabolic process GO:0008202 9.13 CYP21A2 CYP1A2 CYP17A1
8 glucocorticoid biosynthetic process GO:0006704 8.62 CYP21A2 CYP17A1

Molecular functions related to Cytochrome P450 Oxidoreductase Deficiency according to GeneCards Suite gene sharing:

(showing 5, show less)
# Name GO ID Score Top Affiliating Genes
1 oxidoreductase activity GO:0016491 9.56 POR CYP21A2 CYP1A2 CYP17A1
2 heme binding GO:0020037 9.33 CYP21A2 CYP1A2 CYP17A1
3 electron transfer activity GO:0009055 9.32 POR CYP1A2
4 iron ion binding GO:0005506 9.13 CYP21A2 CYP1A2 CYP17A1
5 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen GO:0016705 8.8 CYP21A2 CYP1A2 CYP17A1

Sources for Cytochrome P450 Oxidoreductase Deficiency

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....